Evidence map›Paper›PMID 41472692›Full record

ArticleResearch square2025

Endothelial defects unveil cardiovascular phenotype in iPSC-based disease modelling across three generations of a DiGeorge syndrome family.

Tünde Berecz, Brigitta Szabó, Ábel Fóthi, Andrea Ágnes Molnár, Kristóf Árvai, Leila Holub, Irén Haltrich, Katalin Vincze, György Várady, Tamás I Orbán and 6 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tünde BereczInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
Brigitta SzabóInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
Ábel FóthiInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
Andrea Ágnes MolnárHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Kristóf ÁrvaiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Leila HolubDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Irén Haltrich2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Katalin VinczeInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
György VáradyInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
Tamás I OrbánInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.
János Kriston-ViziLaboratory for Molecular Cell Biology, Medical Research Council, University College London.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Laura KerosuoNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
János M RéthelyiDepartment of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
Gábor FöldesHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Ágota ApátiInstitute of Molecular Life Sciences, HUN-REN RCNS, Budapest, Hungary.ORCID 0000-0003-0380-8139

Funding

Genomic and Computational Biology Support for NIDCD Intramural ResearchZICDC000086 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI MORELL, ROBERT J · 2015 to 2025
$19.8M
Neural Crest Development and DiseaseZIADE000748 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI KEROSUO, LAURA · 2018 to 2025
$11.5M
Intramural NIH HHS ZIA DE000748Intramural NIH HHS ZIC DC000086
6 · The paper itself

Abstract

DiGeorge syndrome (DGS) is caused by a microdeletion on chromosome 22, leading to variable disease phenotypes and severity and often involving congenital cardiovascular disease. In this work, we performed a detailed study of DGS patients with increasing severity within a family of three generations. Genetic analyses revealed no correlation between DGS severity and the size of the deletion or the number of overall genetic variants; however, we identified potentially high-impact variants, indicating a role for these genes in predisposition to the disease. For a phenotypic analysis, induced pluripotent stem cells (iPSCs) were generated and differentiated into functional cardiomyocytes and endothelial cells using blood cells from family members. In DGS patients, the iPSC-derived cardiomyocyte clusters during differentiation showed morphological differences in sarcomere arrangement along with lower cardiac connexin-43 expression. These findings indicate an impaired structural development due to an altered expression of gap junction proteins and cardiomyocyte-matrix connections as a basis of cardiovascular pathology. In endothelial cells differentiated from iPSCs of the DGS patients, we found an aberrant vascular phenotype. Vascular defects were observed in differentiation and migration, as well as in endothelial tubular morphology, accompanied by altered transcription patterns for angiogenesis and vascular integrity pathways. These results suggest that DGS-specific cell types differentiated from hiPSC show major alterations and may be used to uncover genotype-phenotype correlations with the potential to reveal the molecular basis of the clinical manifestations in DGS.

Indexed as

cardiovascular disease modelsDiGeorge syndromepluripotent stem cells

Identifiers

PMID41472692
PMCPMC12747295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.